Advances in the development of new tuberculosis drugs and treatment regimens.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 388, doi. 10.1038/nrd4001
- By:
- Publication type:
- Article
Works matching IS 14741776 AND DT 2013 AND VI 12 AND IP 5
Results: 26
1
2
Henry Chesbrough.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 338, doi. 10.1038/nrd4008
- By:
- Publication type:
- Article
3
Translational medicine: mitigating risks for investigators.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 327, doi. 10.1038/nrd4005
- By:
- Publication type:
- Article
4
Lead identification: Better HSP90 inhibitors.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 346, doi. 10.1038/nrd4019
- By:
- Publication type:
- Article
5
Animal models: A speedy route to mutant mice.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 346, doi. 10.1038/nrd4020
- By:
- Publication type:
- Article
6
Advances in the development of new tuberculosis drugs and treatment regimens.
- Published in:
- 2013
- By:
- Publication type:
- journal article
7
Platforms for antibiotic discovery.
- Published in:
- 2013
- By:
- Publication type:
- journal article
8
Kinase inhibitors: Double duty.
- Published in:
- 2013
- By:
- Publication type:
- journal article
9
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 336, doi. 10.1038/nrd4007
- By:
- Publication type:
- Article
10
Tumour vaccination: Devil in the details of adjuvant choice.
- Published in:
- 2013
- By:
- Publication type:
- journal article
11
Trial watch: Sepsis study failure highlights need for trial design rethink.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 334, doi. 10.1038/nrd4016
- By:
- Publication type:
- Article
12
Commercial prospects for genomic sequencing technologies.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 341, doi. 10.1038/nrd4006
- By:
- Publication type:
- Article
13
Implementing personalized cancer genomics in clinical trials.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 358, doi. 10.1038/nrd3979
- By:
- Publication type:
- Article
14
Vaccines: Bacterial minicells could offer safer vaccines.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 346, doi. 10.1038/nrd4021
- By:
- Publication type:
- Article
15
Mini-Sentinel saves dabigatran.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 333, doi. 10.1038/nrd4055
- Publication type:
- Article
16
Trial watch: PDE4 inhibitor leads wave of target-specific oral psoriasis drugs.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 335, doi. 10.1038/nrd4017
- By:
- Publication type:
- Article
17
Anticancer drugs: Presenting for service.
- Published in:
- 2013
- By:
- Publication type:
- journal article
18
Platforms for antibiotic discovery.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 371, doi. 10.1038/nrd3975
- By:
- Publication type:
- Article
19
Blood disorders: Boosting the stem cell harvest.
- Published in:
- 2013
- By:
- Publication type:
- journal article
20
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 325, doi. 10.1038/nrd4004
- Publication type:
- Article
21
Anticoagulants: An antidote to factor Xa inhibitors.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 346, doi. 10.1038/nrd4022
- By:
- Publication type:
- Article
22
Maturing antibody-drug conjugate pipeline hits 30.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 329, doi. 10.1038/nrd4009
- By:
- Publication type:
- Article
23
FDA issues Alzheimer's rethink.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 333, doi. 10.1038/nrd4086
- Publication type:
- Article
24
Infectious diseases: Novel agents fight flu infection.
- Published in:
- 2013
- By:
- Publication type:
- journal article
25
Extracellular vesicles: biology and emerging therapeutic opportunities.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 347, doi. 10.1038/nrd3978
- By:
- Publication type:
- Article
26
Big expectations for Biogen's small MS drug.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 5, p. 333, doi. 10.1038/nrd4087
- Publication type:
- Article